Access cutting-edge covid-19 treatment through this clinical trial at a research site in Springfield. Study-provided care at no cost to qualified participants.
Access covid-19 specialists in Springfield at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 treatment provided free
The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19. This study is seeking participants 18 through 64 years of age who are considered to be at higher risk for severe COVID-19 disease per study protocol and those 65 years of age and older. All participants in this study will receive 1 shot to their arm of a BNT162b2 (Omi LP.8.1) 30 µg RNA-based vaccine which targets a circulating variant of SARS-CoV-2 and is selected for
Sponsor: BioNTech SE
Check if you qualify for this covid-19 clinical trial in Springfield, MO
If you're searching for covid-19 treatment options in Springfield, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.